Today: 2 May 2026
Broadcom earnings week: Baird and Oppenheimer stick with Buy calls as AVGO options heat up
2 March 2026
2 mins read

Broadcom earnings week: Baird and Oppenheimer stick with Buy calls as AVGO options heat up

NEW YORK, March 2, 2026, 07:42 (EST)

  • Robert W. Baird stuck with its Buy call on Broadcom, keeping the $420 price target in place just before the company’s quarterly results.
  • Rick Schafer at Oppenheimer stuck with his $450 target on Broadcom, saying AI-fueled demand puts the company in position to top estimates.
  • Seeking Alpha analysts highlighted put-selling before earnings, with options premiums still running high.

Broadcom is set to deliver its quarterly results this week, and Robert W. Baird is holding on to its Buy rating, keeping the price target at $420, a note cited by a report said. The firm’s stance rests on what it sees as solid demand for Broadcom’s custom chips powering artificial intelligence systems, according to the report.

Timing’s the key here. Chip stocks have swung around since Nvidia’s results, and investors are watching for a clearer signal: is the AI buildout still turning into fresh orders and real pricing power for hardware suppliers?

Broadcom’s business is a mix that complicates any read on its earnings. The company pushes semiconductors into both phones and data centers, yet its portfolio is full of infrastructure software—think VMware and past acquisitions. That software segment can soften any slowdown, though it also blurs the margin picture.

Oppenheimer’s Rick Schafer is betting Broadcom beats the Street’s targets—$19.2 billion in revenue and $2.02 per share for its fiscal first quarter—according to TipRanks. Schafer left his Outperform rating and $450 price target untouched, citing demand from AI that could help counter some weakness in wireless as Apple brings chipmaking in-house. He also pointed to a possible edge over Qorvo in a coming iPhone refresh. “AVGO boasts the No. 2 AI franchise (after NVDA),” Schafer noted. “We remain long-term buyers.” TipRanks

Lucas Ma, writing as Envision Research for Seeking Alpha, suggested a put-selling approach ahead of the earnings release. With put options, buyers secure the right to sell shares at a predetermined price; sellers pocket the premium but risk having to buy the stock if it falls. According to Ma, with put-call ratios dropping and implied volatility running high—factors that are driving up option premiums—investors might “potentially buy” Broadcom at roughly a 30-times earnings multiple and a PEG of 0.95, measuring valuation versus growth. Seeking Alpha

Broadcom isn’t just sticking to its well-known chips—it’s been ramping up efforts in AI-adjacent plumbing, too. Harish Bharadwaj, a vice president at the company, told Reuters that clients are embracing Broadcom’s stacked-chip technology to get more performance while using less energy. “Now, pretty much all of our customers are adopting this technology,” Bharadwaj said. Reuters

Broadcom plans to release its fiscal first-quarter 2026 numbers after the market closes on Wednesday, March 4, with a conference call set for 2 p.m. Pacific, according to the company.

Broadcom shares were last seen changing hands at $319.55, roughly 0.7% lower than the previous close, according to available market data before the U.S. session kicked off Monday.

There’s a catch: “good” results might not cut it. An analysis from Investing.com flagged the risk of a post-earnings drop in Broadcom shares, even if the company tops forecasts. Margins falling short or a management team hesitant about the staying power of AI demand could spook investors. Investing.com South Africa

Investors are watching three things: AI chip sales and order outlooks, any hints of margin squeeze from bespoke chips, and whether software demand stays resilient as firms rethink budgets and ramp up automation using AI.

Stock Market Today

  • Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan
    May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could pressure margins. Forecasts project ¥1.38 trillion revenue and ¥517 billion earnings by 2028, implying modest growth. Analysts remain divided, with some optimistic on AI-driven pipeline advancements, while others caution on pricing and competitive threats. The governance changes highlight an evolving incentive model as Chugai navigates opportunities and challenges in biologics and Roche partnership dynamics.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026
LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 1:35 AM EDT Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could
US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
Chevron stock nears $200 as oil spikes — and three new takes disagree on CVX value
Previous Story

Chevron stock nears $200 as oil spikes — and three new takes disagree on CVX value

Sasol share price jumps as oil spike shakes markets — what JSE investors watch next
Next Story

Sasol share price jumps as oil spike shakes markets — what JSE investors watch next

Go toTop